About the Authors
- Nuha R. Mansour
-
Contributed equally to this work with: Nuha R. Mansour, Ross Paveley
Affiliation Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
- Ross Paveley
-
Contributed equally to this work with: Nuha R. Mansour, Ross Paveley
Affiliation Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
- J. Mark F. Gardner
-
Affiliation Salvensis, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom
- Andrew S. Bell
-
Affiliation Salvensis, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom
- Tanya Parkinson
-
* E-mail: tan.parkinson@gmail.com
Affiliation Salvensis, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom
- Quentin Bickle
-
Affiliation Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: JMFG, TP, and ASB were previously employed by and own shares in Pfizer, who provided one of the compound collections we screened.
Author Contributions
Conceived and designed the experiments: NRM RP QB JMFG ASB TP. Performed the experiments: NRM RP QB. Analyzed the data: NRM RP QB JMFG ASB TP. Contributed reagents/materials/analysis tools: NRM RP QB ASB JMFG. Wrote the paper: NRM RP QB JMFG ASB TP. Obtained Schistosoma mansoni strain: QB. Negotiated access to compound collections: JMFG.